Evidence and research

• Newborn bloodspot screening policies and standards

  The Screening Division of Public Health Wales is responsible for the planning, preparation and delivery of the Newborn Bloodspot Screening Wales (NBSW) programme. The programme offers every newborn baby who […]

• Newborn bloodspot screening annual report 2017 to 2018

  This report is a detailed summary of information on work undertaken by Newborn Bloodspot Screening Wales for the financial year from April 2017 to the end of March 2018. Results […]

• Newborn bloodspot screening annual report 2018 to 2019

  This report is a detailed summary of information on work undertaken by Newborn Bloodspot Screening Wales for the financial year from April 2018 to the end of March 2019. Results […]

• Newborn bloodspot screening annual report 2019 to 2020

  This report is a detailed summary of information on work undertaken by Newborn Bloodspot Screening Wales for the financial year from April 2019 to the end of March 2020. Results […]

• Newborn bloodspot screening annual report 2020 to 2021

  This report is a detailed summary of information on work undertaken by Newborn Bloodspot Screening Wales for the financial year from April 2020 to the end of March 2021. Results […]

• Newborn bloodspot screening annual report 2021 to 2022

  This report is a detailed summary of information on work undertaken by Newborn Bloodspot Screening Wales for the financial year from April 2021 to the end of March 2022. Results […]

• WEDINOS Nitazenes within the illicit benzodiazepine market

  This WEDINOS report highlights a concerning trend in the UK’s illicit drug market: the infiltration of highly potent synthetic opioids, specifically nitazenes, into substances sold as benzodiazepines. The report underscores […]

• WEDINOS MDMA: ecstasy and apathy

  This WEDINOS report highlights the increasing potency and variability of MDMA (ecstasy) tablets in the UK. The report emphasizes that the strength of MDMA tablets can vary widely, even within […]

• WEDINOS winter watchlist 2015

  This WEDINOS report highlights emerging concerns in the UK’s illicit drug market, particularly the prevalence of Synthetic Cannabinoid Receptor Agonists (SCRAs), synthetic opioids, and misrepresented MDMA samples.

• Pertussis (whooping cough) surveillance and epidemiology

  Epidemiology Pertussis incidence typically has a cyclical pattern with peaks in cases every three to four years. The peak prior to 2012 in England and Wales was in 2008, with […]